Ronda K. Dean
President, CEO & Co-Founder
As a senior executive with more than 25 years of accomplishments in the healthcare and pharmaceutical industries, including leadership of both for-profit and nonprofit organizations, Ronda Dean offers a breadth of experience across various facets of the healthcare industry. Under her leadership, Afaxys has profitably launched 10 oral and two emergency contraceptives and successfully executed a $20 million capitalization strategy.
Prior to her work at Afaxys, Ronda spent 16 years with Parke-Davis Pharmaceuticals, a division of Warner Lambert, where prior to the company’s merger with Pfizer, she served as Vice President and General Manager of Women’s Healthcare, leading a 300-person business unit through a period of accelerated growth. Over the years, she has sat on numerous boards, including Johns Hopkins Medical Institutions, the Storm Eye Institute at Medical University of South Carolina, Wings for Kids, and the Center for Women. She currently serves on the boards of the Coastal Community Foundation of South Carolina and the New Morning Foundation. Ronda holds a Bachelor of Science in Allied Health Sciences from The Ohio State University and an MBA from the Fuqua School of Business at Duke University.